Novartis Zometa

Related by string. * NOVARTIS : maker Novartis AG . Basel Switzerland Novartis . Novartis Pharma AG . Novartis AG NVS . Swiss drugmaker Novartis . Medtronic Novartis Biogen . Sanofi Pasteur Novartis . Novartis AG NYSE NVS / ZOMETA : Zometa zoledronic acid . zoledronic acid Zometa . Zometa administered intravenously . Novartis AG Zometa . Zometa hazard . -Zometa takers . Zometa takers * *

Related by context. All words. (Click for frequent words.) 71 Xgeva 71 Velcade bortezomib 71 Vectibix panitumumab 69 Nexavar sorafenib 69 Torisel 68 Femara letrozole 67 Pfizer Sutent 67 ImClone Erbitux 67 Fablyn 67 Gleevec imatinib 67 denosumab 67 Amgen Vectibix 66 Hycamtin 66 Erbitux cetuximab 66 Ixempra 66 Dendreon Provenge 66 sorafenib Nexavar 66 Noxafil 65 Arixtra 65 ximelagatran 65 BRAF inhibitor 65 Panitumumab 65 bevacizumab Avastin 65 Zometa zoledronic acid 65 Votrient 65 Faslodex 65 Herceptin trastuzumab 65 ixabepilone 65 Novartis Gleevec 65 Xinlay 65 PTK ZK 65 cediranib 65 Arranon 65 pazopanib 65 Folotyn 64 Tavocept 64 Zolinza 64 Zarnestra 64 Avastin bevacizumab 64 Roche Xeloda 64 trastuzumab DM1 64 Amrubicin 64 gadobutrol 64 iniparib 64 MAGE A3 ASCI 64 strontium ranelate 64 tipranavir 64 Removab 64 pertuzumab 64 Denosumab 64 GVAX 64 zoledronic acid Zometa 64 Targretin 64 temsirolimus 64 erlotinib Tarceva 64 Jevtana 64 lasofoxifene 64 elotuzumab 64 anidulafungin 64 tesmilifene 64 XGEVA 63 reslizumab 63 standard chemotherapy regimen 63 Vandetanib 63 Sebivo 63 BCIRG 63 Temsirolimus 63 Dasatinib 63 Canvaxin 63 Arzerra 63 Dacogen decitabine 63 Navelbine ® 63 Sorafenib 63 Sutent sunitinib 63 figitumumab 63 relapsed ovarian cancer 63 panitumumab 63 Sanofi Aventis Taxotere 63 Arcalyst 63 Panzem 63 mapatumumab 63 OHR/AVR# 63 Mylotarg 63 PROCHYMAL 63 metastatic colorectal 63 bicalutamide 63 lumiliximab 63 Tarceva TM 63 AstraZeneca Iressa 63 Bonefos 63 Muraglitazar 62 Torisel temsirolimus 62 Mepact 62 cabazitaxel 62 Asentar 62 palonosetron 62 Taxotere ® 62 Pertuzumab 62 recurrent glioblastoma multiforme 62 TEMODAL 62 Advagraf 62 Celebrex celecoxib 62 Pemetrexed 62 invasive candidiasis 62 ToGA 62 tremelimumab 62 BAY #-# 62 decitabine 62 Treanda 62 HuLuc# 62 gefitinib Iressa 62 mTOR inhibitor 62 rFVIIa 62 Factor Xa inhibitor 62 edifoligide 62 tocilizumab 62 Aflibercept 62 Gleevec imatinib mesylate 62 Nuvion 62 mycophenolate mofetil 62 Onrigin 62 Pazopanib 62 Ontak 62 Vorapaxar 62 Afatinib 62 sunitinib malate 62 canakinumab 62 Erbitux 62 Revlimid lenalidomide 62 posaconazole 62 RSR# 62 aflibercept 62 intravenous bisphosphonates 62 Arimidex anastrozole 62 Apixaban 62 FTY# 62 tecarfarin 62 nonsmall cell lung cancer 62 TYGACIL 62 vemurafenib 62 Zactima 62 ZOLINZA 62 Exemestane 62 Zemplar 62 Roche Herceptin 62 TORISEL 62 mTOR inhibitors 62 Dificid 62 Kynapid 62 Atrasentan 62 Xelox 62 malignant ascites 61 rituximab Rituxan 61 TroVax ® 61 Xyotax 61 Pirfenidone 61 Dabigatran 61 blood clot preventer 61 NATRECOR ® 61 Cancidas 61 lenalidomide Revlimid 61 Aptivus 61 Lilly Gemzar 61 Enbrel etanercept 61 abiraterone 61 aromatase inhibitors AIs 61 PROMACTA 61 Abiraterone 61 cetuximab Erbitux 61 Starlix 61 Tesmilifene 61 ZACTIMA 61 Gliadel Wafer 61 RANK Ligand pathway 61 statin Crestor 61 sorafenib tablets 61 pain palliation 61 regorafenib 61 Nexavar ® 61 Actimmune ® 61 Genentech Roche 61 Glaxo Tykerb 61 Degarelix 61 ACZ# 61 Abraxane 61 darapladib 61 Vertex hepatitis C 61 YONDELIS 61 Aprotinin 61 Eliquis 61 ISEL 61 olaparib 61 etanercept Enbrel 61 metastatic renal cell carcinoma 61 Tanespimycin 61 ranibizumab Lucentis 61 vandetanib 61 gastrointestinal stromal tumors GIST 61 Reverset 61 mRCC 61 gastrointestinal stromal tumors 61 Celgene Revlimid 61 BioNumerik 61 Tykerb lapatinib 61 JAK inhibitor 61 HuMax CD# 61 ACUITY trial 61 PROSTVAC VF 61 Targretin capsules 61 Amevive 61 Teriparatide 61 ASA# 61 Sapien valve 61 Amgen denosumab 61 Cabazitaxel 61 iclaprim 61 Kepivance 61 Cimzia 61 Factor Xa inhibitors 61 Fusilev 61 RhuDex R 61 Proxinium TM 61 Iressa gefitinib 61 infliximab Remicade 61 Victrelis 61 axitinib 61 atrasentan 61 sipuleucel T 61 Avastin 61 STRIDE PD 61 Taxotere docetaxel 61 basiliximab 61 SUTENT 61 DU #b 61 Onconase 61 NSABP C 61 Stenting Trial CREST 61 Rezular 61 noscapine 61 hematological malignancy 61 ADAGIO study 60 teriflunomide 60 pomalidomide 60 atorvastatin Lipitor 60 Egrifta 60 Zometa 60 darunavir 60 Roche Avastin 60 Maraviroc 60 SIR Spheres 60 OncoVex 60 pediatric malignancies 60 CYPHER Stent 60 Genentech Rituxan 60 FOLFIRINOX 60 GnRH agonists 60 Cinquil 60 differentiated thyroid 60 eplerenone 60 Teriflunomide 60 Ilaris 60 Amgen Prolia 60 YERVOY 60 renal toxicity 60 Renal Cell Carcinoma RCC 60 Merck KGaA Erbitux 60 Taxol paclitaxel 60 Acapodene 60 Gilead Viread 60 fluvastatin 60 Bezielle 60 OPAXIO 60 ocrelizumab 60 Peginterferon alfa 2b 60 riociguat 60 brivaracetam 60 NV1FGF 60 Allovectin 7 60 SNT MC# 60 Atacand 60 IV bisphosphonates 60 alendronate Fosamax 60 SEBIVO 60 deferiprone 60 recurrent GBM 60 Erlotinib 60 samalizumab 60 relapsed MM 60 UCB Cimzia 60 Gemzar 60 Vivus Qnexa 60 efalizumab 60 Actos pioglitazone 60 T DM1 60 Ethyol 60 Doxil ® 60 RE LY 60 metastatic hormone refractory 60 RhuDex 60 Alimta pemetrexed 60 Rilutek 60 Zocor simvastatin 60 anti TNFs 60 thalidomide Thalomid 60 PROSTVAC TM 60 Bayer Nexavar 60 Ceflatonin 60 midstage clinical 60 panitumumab Vectibix 60 BR.# study 60 AVADO 60 ARCOXIA 60 levosimendan 60 Certican 60 Vectibix 60 Romiplostim 60 arzoxifene 60 Lucentis ranibizumab 60 Neulasta ® 60 Merck Januvia 60 Stelara 60 Firazyr 60 liprotamase 60 bortezomib Velcade 60 glitazones 60 PROLARIS 60 zoledronic acid 60 Everolimus 60 MICARDIS ® 60 eltrombopag 60 angiogenesis inhibition 60 Gleevac 60 sorafenib 60 post menopausal osteoporosis 60 EndoTAG TM -1 60 PrevOnco 60 Neuvenge 60 Candesartan 60 elacytarabine 60 Eli Lilly Gemzar 60 NOXAFIL 60 motesanib 60 SERMs 60 lapatinib Tykerb 60 ticlopidine 60 Hexvix 60 Sutent sunitinib malate 60 investigational therapies 60 custirsen 60 platelet inhibitor 60 Paraplatin 60 OvaRex ® MAb 60 Rasagiline 60 Campath alemtuzumab 60 neratinib 60 Genentech Herceptin 60 Fulvestrant 60 ancrod 60 ACCORD Lipid 59 Gefitinib 59 TYZEKA 59 aprepitant 59 Eltrombopag 59 pediatric acute lymphoblastic 59 concurrent chemoradiation 59 eritoran 59 Bayer Onyx 59 Sprycel dasatinib 59 Halaven 59 bazedoxifene 59 rhThrombin 59 Gilenia 59 Octreolin 59 TroVax 59 AstraZeneca Brilinta 59 Advexin 59 oxymorphone ER 59 EGFR inhibitors 59 Dacogen injection 59 Hepatocellular Carcinoma HCC 59 Vidofludimus 59 Silodosin 59 trastuzumab Herceptin ® 59 AA Amyloidosis 59 anastrozole 59 Prasugrel 59 ARIMIDEX 59 Avandia rosiglitazone 59 sunitinib Sutent 59 Nexavar 59 Prostate AdenoCarcinoma Treatment 59 GSK# [001] 59 oral ridaforolimus 59 oral FTY# 59 anticlotting drug 59 CBLC# 59 Onco TCS 59 Aplidin 59 Elan Tysabri 59 Telcyta 59 Mycamine 59 Rezonic 59 Cetuximab 59 Aclasta 59 proteasome inhibitor 59 ruboxistaurin 59 enzastaurin 59 chemotherapeutic regimen 59 malignant pleural mesothelioma 59 NSABP 59 pegylated liposomal doxorubicin 59 rivaroxaban 59 Boceprevir 59 vismodegib 59 antiplatelet agent 59 Theratope 59 Instanyl 59 Rilonacept 59 clodronate 59 Epivir 59 Tykerb 59 Adjuvant chemotherapy 59 dexpramipexole 59 Rasilez Tekturna 59 Gleevec Glivec 59 clazosentan 59 relapsed SCLC 59 cilostazol 59 docetaxel Taxotere ® 59 prasugrel 59 Allovectin 7 ® 59 GW# [003] 59 Tarceva erlotinib 59 neoadjuvant therapy 59 Hepsera 59 Xarelto 59 Cethrin 59 Promacta 59 rNAPc2 59 Fibrillex TM 59 Doxil 59 Certolizumab pegol 59 Camptosar ® 59 Protelos 59 Daclizumab 59 Tyrima 59 Eculizumab 59 DAPT 59 Angiolix 59 blood thinner Xarelto 59 microtubule inhibitor 59 STELARA ™ 59 bucindolol 59 tafamidis 59 visilizumab 59 Syncria 59 PSMA ADC 59 xanthine oxidase inhibitor 59 exenatide Byetta 59 Rivaroxaban 59 raloxifene Evista 59 Hycamtin ® 59 Sensipar 59 Aclidinium 59 drug eluting coronary stents 59 Rebif ® 59 ustekinumab 59 Dalbavancin 59 Satraplatin 59 HuMax EGFr 59 Mipomersen 59 APTIVUS R 59 Aromasin 59 Orencia 59 Betaferon ® 59 motavizumab 59 abiraterone acetate 59 canagliflozin 59 receptor tyrosine kinase inhibitor 59 Abacavir 59 SCD HeFT 59 thromboembolic disease 59 BRIM2 59 pantoprazole 59 chemoradiotherapy 59 multi kinase inhibitor 59 Golimumab 59 tasocitinib 59 phase IIb clinical 59 ReoPro 59 LY# [003] 59 Taxotere 59 Cimzia TM 59 Bevacizumab Avastin 59 PF # [002] 59 goserelin 59 Subgroup analysis 59 Tocosol Paclitaxel 59 INTEGRILIN 59 amrubicin 59 Taxus Liberte 59 BZL# 59 Zenapax 59 IRX 2 59 budesonide foam 59 Irinotecan 59 Orazol 59 Levetiracetam 59 IMiDs 59 Dacogen 59 Crizotinib 59 Orencia abatacept 59 Arimoclomol 59 HCV RESPOND 2 59 heterozygous FH 59 Rituxan rituximab 59 trastuzumab Herceptin 59 D mab 59 CIMZIA ™ 59 Doribax 59 allogeneic HSCT 59 interferon gamma 1b 59 letrozole Femara 59 atacicept 59 stage IIIB IV 59 Epirubicin 59 recurrent metastatic 59 Tocosol 59 dacetuzumab 59 Viramidine 59 intravenous cyclophosphamide 59 vidofludimus 59 Vertex telaprevir 59 mertansine 59 Virulizin ® 59 MYDICAR ® 59 Zybrestat 59 otelixizumab 59 adjuvant therapies 59 Abbott Humira 59 Lapatinib 59 midstage trials 59 idraparinux 59 Certriad 59 antiangiogenic therapy 59 ULORIC 59 RhuDex ® 59 SCCHN 59 Tasigna nilotinib 58 Letrozole 58 Humira adalimumab 58 Viviant 58 azacitidine 58 VIDAZA 58 bone metastasis 58 Nuedexta 58 CoFactor 58 Glypromate 58 pegaptanib 58 DEB# 58 perampanel 58 candesartan 58 recurrent NSCLC 58 LEUKINE 58 anticancer therapies 58 COX 2s 58 Taxotere chemotherapy 58 palifermin 58 Bevacizumab 58 Ophena TM 58 Vectibix monotherapy 58 NovoTTF 58 Aliskiren 58 Avandia Actos 58 TAXUS Liberte Stent 58 Alemtuzumab 58 Arzerra ofatumumab 58 IRESSA 58 mecamylamine 58 Plaquenil 58 Simponi golimumab 58 adalimumab Humira 58 CLARITY study 58 anakinra 58 Amplimexon 58 AstraZeneca Crestor 58 Trandolapril 58 ularitide 58 LHRH agonists 58 Actemra tocilizumab 58 Prolia 58 muraglitazar 58 PREOS 58 Symadex 58 QNEXA 58 Ophena 58 Pegintron 58 Tamsulosin 58 Actemra 58 Camptosar 58 Roche Actemra 58 vorinostat 58 cilengitide 58 Revlimid 58 rotigotine transdermal patch 58 oral Xeloda 58 Tekturna aliskiren 58 HPTN 58 tipranavir ritonavir 58 Omapro 58 Evista 58 Vernakalant 58 Dapagliflozin 58 HIF PHI 58 AEGR 58 Novartis Diovan 58 methylnaltrexone 58 pradefovir 58 cinacalcet 58 DXL# 58 midstage studies 58 R sorafenib tablets 58 Carfilzomib 58 PD LID 58 TKI therapy 58 inhibitor RG# 58 zoledronate 58 dasatinib 58 topotecan 58 pegfilgrastim 58 FOLPI 58 galiximab 58 Toremifene 58 direct thrombin inhibitors 58 dirucotide 58 ADVEXIN therapy 58 placebo controlled clinical 58 MitraClip device 58 paclitaxel poliglumex 58 ATACAND 58 reboxetine 58 Uloric 58 chemopreventive agent 58 Yervoy 58 belatacept 58 Zevalin consolidation 58 NATRECOR R 58 biphosphonates 58 MADIT CRT 58 cinacalcet HCl 58 AVASTIN 58 Integrilin 58 FOLFOX4 58 Kivexa 58 cangrelor 58 Laquinimod 58 sunitinib 58 dabigatran 58 Glucophage XR 58 acyclovir Lauriad R 58 TNF alpha inhibitors 58 Crestor rosuvastatin 58 vildagliptin 58 Virulizin 58 PegIntron 58 Aceon 58 tarenflurbil 58 RANK Ligand inhibitor 58 Aviptadil 58 thiazolidinediones TZDs 58 Orexigen Contrave 58 bone metastases 58 glucocorticoid induced osteoporosis 58 selenium supplementation 58 antitumor effect 58 IMA# 58 HQK 58 anti angiogenic therapy 58 NEUPOGEN 58 MADIT CRT trial 58 aromatase inhibitor therapy 58 RE LY ® 58 cathepsin K inhibitor 58 Potiga 58 Rosiglitazone 58 Xigris 58 CIMZIA TM 58 metastatic kidney 58 Novartis AG NVS NOVN.VX 58 senicapoc 58 rilonacept 58 ganetespib 58 daclizumab 58 ONGLYZA ™ 58 Adentri 58 pegylated interferons 58 FASLODEX 58 romiplostim 58 Azedra 58 Novartis AG Gleevec 58 idiopathic pulmonary fibrosis IPF 58 paclitaxel Taxol 58 TNF blocker 58 orBec 58 flavopiridol 58 amoxicillin clavulanate 58 Inspra 58 Cladribine 58 drug Treanda 58 Lorianne Masuoka MD 58 fenofibric acid 58 BCR ABL inhibitor 58 corticosteroid dexamethasone 58 PROactive study 58 K ras mutations 58 AZILECT ® 58 ProSavin 58 Abatacept 58 docetaxel Taxotere R 58 Evoltra 58 teriparatide 58 MYDICAR 58 Defibrotide 58 glatiramer 58 docetaxel chemotherapy 58 non squamous NSCLC 58 Glufosfamide 58 EndoTAGTM 1 58 Aclasta Reclast 58 novel oral anticoagulant 58 Vfend 58 Fludara 58 Bifeprunox 58 Archexin 58 XmAb# 58 Cytoxan 58 paricalcitol 58 flutamide 58 APPRAISE 58 PANVAC VF 58 Ataluren 58 multicenter trials 58 APTIVUS 58 Factor VIIa 58 Avastin Tarceva 58 Avanafil 58 Rituxan 58 metastatic castration resistant 58 ticagrelor 58 rThrombin 58 aldosterone antagonists 58 anti angiogenic agent 58 cholinesterase inhibitors 58 lenalidomide Revlimid R 58 DPP4 inhibitor 58 Zavesca R 58 oral JAK1 58 EDEMA3 58 Accolate 58 CCR5 antagonist 58 clinical pharmacology studies 58 Riluzole 58 HER2 positive metastatic breast 58 Eribulin 58 PLX# 58 MyVax 58 Proleukin 58 modulators SERMs 58 candidemia 58 Procoralan 58 Valcyte 58 HCV SPRINT 58 TRISENOX 58 Emend 58 clopidogrel Plavix 58 antihormonal 58 Randomized clinical trials 58 Phase IIb clinical trials 58 Pixuvri 58 RoActemra 58 trabectedin 57 AOD# [002] 57 Tarvacin 57 gemcitabine carboplatin 57 apremilast 57 Imiquimod 57 RSD# oral 57 LAF# 57 Bucindolol 57 sargramostim 57 INSPIRE Trial Phase III 57 IL# PE#QQR 57 CONBRIZA 57 vaccine RotaTeq 57 CCR5 antagonists 57 efavirenz Sustiva 57 QuadraSphere 57 Zemplar Capsules 57 adjuvant radiotherapy 57 Urocidin 57 PRT# 57 Afinitor everolimus 57 bendamustine 57 interferon beta therapy 57 roflumilast 57 Raptiva ® 57 HepaMate 57 Millennium Velcade 57 Cethromycin 57 testosterone supplementation 57 Hydroxyurea 57 Imatinib 57 UPLYSO 57 MabCampath 57 Pruvel 57 phase IIa clinical 57 VADT 57 ACTEMRA TM 57 Neoadjuvant 57 Cloretazine 57 Carvedilol 57 Baraclude 57 venous thromboembolic events 57 Cetrorelix 57 Celsentri Selzentry 57 oral anticoagulation 57 oral rivaroxaban 57 Mirapexin 57 PRADAXA 57 VIMOVO 57 Ranibizumab 57 indibulin 57 Mimpara 57 SUTENT ® 57 Corlux 57 Sorafenib Nexavar 57 Telbivudine 57 cladribine 57 percutaneous cryoablation 57 dalteparin 57 non resectable metastatic 57 VA# [002] 57 PRoFESS 57 Colazal 57 complete cytogenetic response 57 rosuvastatin Crestor 57 randomized Phase IIb 57 tanespimycin 57 gp# vaccine 57 TACI Ig 57 invasive aspergillosis 57 Tyverb 57 Oxaliplatin 57 Pargluva 57 Gleevec 57 Fibrin Pad 57 intensive statin therapy 57 tipifarnib 57 Cerovive 57 gemcitabine chemotherapy 57 Entecavir 57 alemtuzumab 57 Zoledronic acid 57 Sanofi Acomplia 57 PTK# 57 Xiaflex 57 multiple myeloma MM 57 BRIM3 57 CytoFab 57 fulvestrant 57 tamoxifen Nolvadex ® 57 TNF antagonist 57 metastatic RCC 57 Vicinium TM 57 OZURDEX ® 57 CALGB 57 CCR5 receptor antagonist 57 Eli Lilly Cymbalta 57 Zavesca 57 valopicitabine 57 Virulizin R 57 CHAMPION PCI 57 PROSTVAC ® 57 interferon alfa 57 RX Acculink 57 humanised monoclonal antibody 57 fenofibrate 57 Fondaparinux 57 ADVANCE PD 57 Aptivus ® 57 Genentech Tarceva 57 Enzastaurin 57 refractory CLL 57 Alzhemed 57 angiogenesis inhibitors 57 Fareston 57 GSK# [002] 57 R roscovitine 57 eprotirome 57 nilotinib 57 nonmelanoma skin cancers 57 Solorel 57 Olaparib 57 Cipralex ® 57 preclinically 57 adjuvant endocrine therapy 57 EFAPROXYN 57 nucleotide analogue 57 EORTC 57 superficial bladder cancer 57 TRITON TIMI 57 Ozarelix 57 calcineurin inhibitor 57 Amyvid 57 MabThera rituximab 57 heparins 57 TASKi3 57 gepirone ER 57 multicenter Phase II 57 Telavancin 57 Avodart 57 fenretinide 57 gemcitabine Gemzar 57 nucleoside analogues 57 micafungin 57 Affinitak 57 dalbavancin 57 antiplatelet drugs 57 squamous histology 57 Xanafide 57 adjuvant colon cancer 57 prognostic variables 57 exemestane 57 tyrosine kinase inhibitor 57 INCB# [003] 57 LymphoStat B belimumab 57 macrolide antibiotics 57 Alvesco R 57 conjugated estrogens 57 preoperative chemotherapy 57 angiographic outcomes 57 Campath 57 calcineurin inhibitors 57 Evoltra ® 57 entecavir 57 Femara 57 levetiracetam Keppra 57 basal cell carcinoma BCC 57 AVANDIA 57 virotherapy 57 TLK# 57 KRAS status 57 ibandronate 57 Neurodex 57 everolimus Afinitor 57 masitinib 57 Provenge prostate cancer 57 exemestane Aromasin 57 KRAS mutation 57 LHRH antagonists 57 pegylated interferon alfa 57 CB1 antagonists 57 Combination therapy 57 evaluating REVLIMID 57 solanezumab 57 CINQUIL 57 Folfox 57 lomitapide 57 Telaprevir 57 CALGB # [001] 57 carvedilol 57 Brilique 57 Multicenter Automatic Defibrillator Implantation 57 recurrent ovarian cancer 57 Sandostatin LAR Depot 57 eflornithine 57 recurrent glioma 57 anti angiogenic agents 57 Sporanox 57 Ocrelizumab 57 BR.# 57 Leukine 57 BrachySil TM 57 anticlotting drugs 57 Platinol 57 LymphoStat B 57 Cimzia certolizumab pegol 57 trastuzumab emtansine T DM1 57 Inegy 57 fondaparinux 57 Anastrozole 57 Troxatyl 57 sitaxsentan 57 curative therapy 57 Traficet EN 57 frovatriptan 57 pancreatic adenocarcinoma 57 AIM HIGH 57 EOquin

Back to home page